デフォルト表紙
市場調査レポート
商品コード
1405896

臨床検査室試験の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2024年~2030年

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing), By End-use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 104 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
臨床検査室試験の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2024年~2030年
出版日: 2023年12月26日
発行: Grand View Research
ページ情報: 英文 104 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査室試験市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の臨床検査室試験市場規模は2030年までに2,130億4,000万米ドルに達し、2024年から2030年までのCAGRは9.2%で拡大すると予測されています。

臨床検査室試験市場の成長は、対象疾患の有病率の上昇に起因しています。臨床検査室検査の使用は、適切な診断と治療の評価と策定につながる患者の健康に主に焦点を当てた多種多様な診断目的での検査の使用により増加傾向にあります。

世界の老年人口は増加しており、心血管疾患や腎機能障害などの疾患発症の最大の危険因子であると考えられています。WHOによると、60歳以上の人口は2030年には6人に1人になると予想されており、2020年の10億人から2030年には14億人に増加します。さらに、2050年には80歳以上の人口は15億人以上と倍増し、80歳以上の人口は3倍の4,260億人に達すると予測されています。このように、老人人口の増加は、予測期間中、同市場にとってインパクトの大きい市場促進要因になると予想されます。

CVDや糖尿病などの対象疾患の有病率の増加は、予測期間を通じて市場を押し上げると予想されます。CVDは致死的であり、世界の死因のトップです。心血管疾患に関するアンメット・メディカル・ニーズの高さと、それに伴う患者の意識の高まりは、ポイントオブケア脂質検査の需要を押し上げると予想される要因の一つです。WHOによると、2021年、心血管疾患は過去30年間における世界の死亡率および罹患率の主要原因であり、毎年177億人が心血管疾患により死亡しており、これは世界の全死亡者の31%にあたる。

さらに、臨床検査薬の開発・製剤化に携わる主な企業は、新規の結核治療薬を開発し、市場での競争力を維持するために、共同研究やパートナーシップに注力しています。さらに、検査室自動化システムの採用が増加していることも、予測期間中の市場を押し上げると予想されます。例えば、2023年1月[、BD社は、微生物検査室の検体処理を自動化する第3世代のトータルラボラトリーオートメーションシステムを発売しました。さらに、2023年1月には、NovoPath LLC社が腫瘍検査室向けのLISソリューションを拡充しました。

臨床検査室試験市場レポートハイライト

  • HbA1c検査セグメントは2023年に最大の売上シェアを占め、これは糖尿病人口の増加によるものです。
  • HGB/HCT検査セグメントは、血液関連疾患の有病率の増加により、予測期間中に最も速い成長率を示すと予想されます。
  • 中央検査室部門は2023年に市場を独占したが、これは高い市場普及率と検査件数に起因します。
  • 北米が2023年に最大の市場シェアを占めたが、これは規制当局の支援の拡大と臨床検査への投資の増加に起因しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床検査室試験市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 臨床検査室試験市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 臨床検査室試験市場:タイプの推定・動向分析

  • タイプ市場シェア、2023年および2030年
  • セグメントダッシュボード
  • タイプ別の世界の臨床検査室試験市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 全血球計算
    • HGB/HCT試験
    • 基本的な代謝パネル検査
    • BUNクレアチニン検査
    • 電解質検査
    • HbA1c検査
    • 市場推計・予測、2018~2030年
    • 総合代謝パネル検査
    • 肝臓パネル検査
    • 腎臓パネル検査
    • 脂質パネル検査
    • 心血管パネル検査

第5章 臨床検査室試験市場:最終用途の推定・動向分析

  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の臨床検査室試験市場の見通し
  • 以下の市場規模、予測および動向分析、2018年から2030年まで
    • 中央検査室
    • プライマリークリニック

第6章 臨床検査室試験市場:地域の推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018~2030年:
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • 主要ディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業シェア分析、2023年
    • Abbott
    • CINVEN
    • QUEST DIAGNOSTICS INCORPORATED
    • OPKO HEALTH, INC.
    • F. Laboratory Corporation of America Holdings
    • UNILABS
    • Synnovis Group LLP
    • SONIC HEALTHCARE
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 U.S. clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 10 Europe clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Europe clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Germany clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Norway clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Norway clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 China clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 South Korea clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 38 South Korea clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Australia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Australia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Thailand clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 42 Thailand clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America clinical laboratory tests market, by application, 2018 - 2030 (USD Billion)
  • Table 46 Brazil clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 MEA clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 53 MEA clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 54 MEA clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 South Africa clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 UAE clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical laboratory tests market: market outlook
  • Fig. 14 Clinical laboratory tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical laboratory tests market driver impact
  • Fig. 20 Clinical laboratory tests market restraint impact
  • Fig. 21 Clinical laboratory tests market strategic initiatives analysis
  • Fig. 22 Clinical laboratory tests market: Type movement analysis
  • Fig. 23 Clinical laboratory tests market: Type outlook and key takeaways
  • Fig. 24 CBC market estimates and forecast, 2018 - 2030
  • Fig. 25 HGB/HCT test market estimates and forecast, 2018 - 2030
  • Fig. 26 Basic metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 27 BUN creatinine test market estimates and forecast, 2018 - 2030
  • Fig. 28 Electrolyte tests market estimates and forecast, 2018 - 2030
  • Fig. 29 HbA1c tests market estimates and forecast, 2018 - 2030
  • Fig. 30 Comprehensive metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 31 Liver panel test market estimates and forecast, 2018 - 2030
  • Fig. 32 Hepatitis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 35 Liver cancer liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 36 Bone disease liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 38 Others liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 39 Renal panel test market estimates and forecast, 2018 - 2030
  • Fig. 40 Lipid panel tests market estimates and forecast, 2018 - 2030
  • Fig. 41 Cardiovascular panel test market estimates and forecast, 2018 - 2030
  • Fig. 42 Clinical laboratory tests market: End-use movement Analysis
  • Fig. 43 Clinical laboratory tests market: End-use outlook and key takeaways
  • Fig. 44 Central Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 45 Primary Clinics market estimates and forecasts,2018 - 2030
  • Fig. 46 Global clinical laboratory tests market: Regional movement analysis
  • Fig. 47 Global clinical laboratory tests market: Regional outlook and key takeaways
  • Fig. 48 Global clinical laboratory tests market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Denmark
  • Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 82 Norway
  • Fig. 83 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 84 Asia Pacific
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 86 China
  • Fig. 87 China market estimates and forecasts, 2018 - 2030
  • Fig. 88 Japan
  • Fig. 89 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 90 India
  • Fig. 91 India market estimates and forecasts, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 94 South Korea
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 96 Australia
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Latin America
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 100 Brazil
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 102 Mexico
  • Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 116 Market share of key market players- Clinical laboratory tests market
目次
Product Code: 978-1-68038-361-4

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

  • HbA1c tests segment held largest revenue share in 2023 and is attributable to the increasing prevalence of diabetic population
  • HGB/HCT tests segment is expected to show fastest growth rate over the forecast period owing to the growing prevalence of blood-related disorders
  • Central laboratories segment dominated the market in 2023 attributable to the high market penetration and procedure volumes
  • North America held the largest market share in 2023 which can be attributed to the growing regulatory support and increase in investments in clinical laboratory tests

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Growing prevalence of target disease
      • 3.2.1.3. Introduction of innovative solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. COVID-19 pandemic
  • 3.3. Clinical Laboratory Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Laboratory Tests Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Complete Blood Count
      • 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. HGB/HCT Testing
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3. Basic Metabolic Panel Testing
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.4. BUN Creatinine Testing
      • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.5. Electrolytes Testing
      • 4.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.6. HbA1c Testing
    • 4.4.7. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.8. Comprehensive Metabolic Panel Testing
      • 4.4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.9. Liver Panel Testing
      • 4.4.9.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.2. Hepatitis
      • 4.4.9.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.3. Bile Duct Obstruction
      • 4.4.9.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.4. Liver Cirrhosis
      • 4.4.9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.5. Liver Cancer
      • 4.4.9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.6. Bone Disease
      • 4.4.9.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.7. Autoimmune Disorders
      • 4.4.9.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.8. Others
      • 4.4.9.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.10. Renal Panel Testing
      • 4.4.10.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.11. Lipid Panel Testing
      • 4.4.11.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.12. Cardiovascular Panel Testing
      • 4.4.12.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Laboratory Tests Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Central Laboratories
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. Primary Clinics
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CINVEN
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QUEST DIAGNOSTICS INCORPORATED
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. OPKO HEALTH, INC.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. F. Laboratory Corporation of America Holdings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. UNILABS
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Synnovis Group LLP
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. SONIC HEALTHCARE
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives